Antiviral and anticancer activities of 13(E)-labd-13-ene-8α,15-diol isolated from Brachyglottis monroi

Phytotherapy Research

Volumn 24, Issue 2, 2010, Pages 169-174

  Choi, Hwa Jung ^a   Song, Jae Hyoung ^a   Kwon, Dur Han ^a   Baek, Seung Hwa ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

13(E) labd 13 ene 8 ,15 diol; Anticancer activity; Antiviral activity; Brachyglottis monroi; Human rhinovirus

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; LABD 13 ENE 8ALPHA,15 DIOL; RIBAVIRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BRACHYGLOTTIS MONROI; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DRUG EFFECT; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; IC 50; LARYNX CANCER; LUNG CANCER; MEDICINAL PLANT; NONHUMAN; VIRUS INFECTIVITY; VIRUS PARTICLE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIVIRAL AGENTS; ASTERACEAE; DITERPENES; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; RHINOVIRUS;

BRACHYGLOTTIS; HUMAN RHINOVIRUS 2; HUMAN RHINOVIRUS SP.;

EID: 75849163253     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2875     Document Type: Article

References (24)

1. Bloor SJ, Gainsford GJ. 1993. A novel clerodane-ascorbate adduct from Brachyglottis bidwillii. Aust J Chem 46: 1099-1104.
2. Briskin DP. 2000. Medicinal plants and phytomedicines. Linking plant biochemistry and physiology to human health. Plant Physiol 124: 507-514.
3. Calabuig MT, Cortes M, Francisco CG, Hernandez R, Suarez E. 1981. Labdane diterpenes from Cistus synphytifolius. Phytochemistry 20: 2255-2258.
4. Connor HE, Edgar E. 1987. Name changes in the indigenous New Zealand flora, 1960-1986 and Nomina Nova IV, 1983-1986. N Z J Bot 25: 115-170.
5. Cowan MM. 1999. Plant products as antimicrobial agents. Clin Microbiol Rev 12: 564-582.
6. De Clercq E. 2004. Antiviral drugs in current clinical use. J Clin Virol 30: 115-133.
7. Dimas K, Demetzos C, Marsellos M, Sotiriadou R, Malamas M, Kokkinipoulos D. 1998. Cytotoxic activity of labdane type diterpenes against human leukemic cell lines in vitro. Planta Med 64: 208-211.
8. Garbino J, Gerbase MW, Wunderli W et al. 2004. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med 170: 1197-1203.
9. Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. 1997. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 155: 1159-1161.
10. Ghosh S, Champlin R, Couch R et al. 1999. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis 29: 528-532.
11. Hayden FG. 2004. Rhinovirus and the lower respiratory tract. Rev Med Virol 14: 17-31.
12. Huang X, Kojima-Yuasa A, Xu S et al. 2008. Green tea extract enhances the selective cytotoxic activity of Zizyphus jujuba extracts in HepG2 cells. Am J Chin Med 36: 729-744.
13. Ison MG, Hayden FG, Kaiser L, Corey L, Boeckh M. 2003. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis 36: 1139-1143.
14. Jason DG, Craig EC. 2006. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol 16: 37-48.
15. Jassim SA, Naji MA. 2003. Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol 95: 412-427.
16. Lin ZX, Hoult JRS, Raman A. 1999. Sulforhodamine B assay for measuring proliferation of a pigmented melanocyte cell line and its application to the evalution of crude drugs used in the treatment of vitiligo. J Ethnopharmacol 66: 141-150.
17. Longo L, Platini F, Scardino A, Alabiso O, Vasapollo G, Tessitore L. 2008. Autophagy inhibition enhances anthocyan-ininduced apoptosis in hepatocellular carcinoma. Mol Cancer Ther 7: 2476-2485.
18. Papadopoulos NG, Bates PJ, Bardin PG et al. 2000. Rhinoviruses infect the lower airways. J Infect Dis 181: 1875-1884.
19. Riley M. 1994. Maori Healing and Herbal. Viking Sevenseas N. Z. Ltd: Paraparaumu.
20. Schroth MK, Grimm E, Frindt P et al. 1999. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 20: 1220-1228.
21. Subauste MC, Jacoby DB, Richards SM, Proud D. 1995. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96: 549-557.
22. Verschraegen CF, Jaeckle K, Giovanella B. 2000. Alternative administration of camptothecin analogues. Ann N Y Acad Sci 922: 237-246.
23. Vlietinck AJ, Vanden Berghe DA. 1991. Can ethnopharmacology contribute to the development of antiviral drugs. J Ethnopharmacol 32: 141-153.
24. Williams JE. 2001. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Altern Med Rev 6: 567-579.